Biotinyl-tyramide-based in situ hybridization signal patterns distinguish human papillomavirus type and grade of cervical intraepithelial neoplasia

Modern Pathology

Volumn 15, Issue 12, 2002, Pages 1339-1347

  Evans, Mark F ^a,b   Mount, Sharon L ^a,b   Beatty, Barbara G ^a,b   Cooper, Kumarasen ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Blotinyl tyramide; Cervical intraepithelial neoplasia; Human papillomavirus; In situ hybridization; Integration; Physical status

Indexed keywords

BIOTIN; ISOPROPAMIDE IODIDE; VIRUS DNA;

ARTICLE; BIOTINYLATION; CANCER GRADING; CLINICAL ARTICLE; CORRELATION ANALYSIS; EPITHELIUM TUMOR; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UTERINE CERVIX CARCINOMA IN SITU; VIRUS TYPING; WART VIRUS;

BIOTIN; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; TUMOR VIRUS INFECTIONS; TYRAMINE; UTERINE CERVICAL NEOPLASMS;

EID: 0036905284     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880698     Document Type: Article

References (26)

1. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
2. Meijer CJ, Walboomers JM. Cervical cytology after 2000: Where to go? J Clin Pathol 2000;53:41-3.
3. Syrjanen K, Syrjanen S. Molecular biology of papillomavi-ruses. In: Syrianen K, Syrjanen S, editors. Papillomavirus Infections in Human Pathology. 1st Ed. New York: Wiley; 2000. p. 11-51.
4. Jeon S, Allen-Hoffmann BL, Lambert PF. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 1995;69:2989-97.
5. Southern SA, Herrington CS. Disruption of cell cycle control by human papillomaviruses with special reference to cervical carcinoma. Int J Gynecol Cancer 2000;10:263-74.
6. Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, et al. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci U S A 2000;97:10002-7.
7. Galloway DA, McDougall JK. The disruption of cell cycle checkpoints by papillomavirus oncoproteins contributes to anogenital neoplasia. Semin Cancer Biol 1996;7:309-15.
8. Cooper K, Herrington CS, Stickland JE, Evans MF, McGee JO. Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation. J Clin Pathol 1991;44:990-6.
9. Kristiansen E, Jenkins A, Holm R. Coexistence of episomal and integrated HPV16 DNA in squamous cell carcinoma of the cervix. J Clin Pathol 1994;47:253-6.
10. Berumen J, Unger ER, Casas L, Figueroa P. Amplification of human papillomavirus types 16 and 18 in invasive cervical cancer. Hum Pathol 1995;26:676-81.
11. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, et al. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: The age-related patterns for high-risk and low-risk types. Int J Cancer 2000;87:221-7.
12. Meissner JD. Nucleotide sequences and further characterization of human papillomavirus present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J Gen Virol 1999;80:1725-33.
13. Shirasawa H, Tomita Y, Kubota K, Kasai T, Sekiya S, Takamizawa H, et al. Detection of human papillomavirus type 16 DNA and evidence for integration into the cell DNA in cervical dysplasia. J Gen Virol 1986;67:2011-5.
14. Lehn H, Villa LL, Marziona F, Hilgarth M, Hillemans HG, Sauer G. Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract. J Gen Virol 1988;69:187-96.
15. Daniel B, Mukherjee G, Seshadri L, Vallikad E, Krishna S. Changes in the physical state and expression of human papillomavirus type 16 in the progression of cervical intraepithelial neoplasia lesions analysed by PCR. J Gen Virol 1995;76:2589-93.
16. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol 1992;23:117-28.
17. Fukushima M, Yamakawa Y, Shimano S, Hashimoto M, Sawada Y, Fujinaga K. The physical state of human papillo-mavirus 16 DNA in cervical carcinoma and cervical intraepithelial neoplasia. Cancer 1990;66:2155-61.
18. Cullen AP, Reid R, Campion M, Lorincz AT. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991;65:606-12.
19. Pirami L, Giache V, Becciolini A. Analysis of HPV 16, 18, 31 and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. J Clin Pathol 1997;50:600-4.
20. Das BC, Sharma JK, Gopalakrishna V, Luthra UK. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol 1992;73:2327-36.
21. Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, Schneider A, et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 1999;59:6132-6.
22. Matsukura T, Sugase M. Relationships between 80 human papillomavims genotypes and different grades of cervical intraepithelial neoplasia: Association and causality. Virology 2001;283:139-47.
23. Burghardt E, Ostor AG. Site and origin of squamous cervical cancer: A histomorphologic study. Obstet Gynecol 1983;62:117-27.
24. Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, et al. Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study. Lancet 2001;357:1831-6.
25. Park TW, Richart RM, Sun XW, Wright TC Jr. Association between human papillomavirus type and clonal status of cervical squamous intraepithelial lesions. J Natl Cancer Inst 1996;88:355-8.
26. Evans MF, Koreth J, Bakkenist CJ, Herrington CS, McGee JO. Allelic deletion at 11q23.3-q25 is an early event in cervical neoplasia. Oncogene 1998;16:2557-64.